These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 35806183)

  • 41. Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus.
    Jeppsson A; Sandelius Å; Zettergren A; Kern S; Skoog I; Blennow K; Zetterberg H; Wikkelsø C; Hellström P; Tullberg M
    Fluids Barriers CNS; 2023 Jul; 20(1):54. PubMed ID: 37415175
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis.
    Mariotto S; Gajofatto A; Zuliani L; Zoccarato M; Gastaldi M; Franciotta D; Cantalupo G; Piardi F; Polo A; Alberti D; Sartori S; Zanusso G; Agrò L; Demurtas R; Sechi G; Sechi E; Monaco S; Ferrari S
    J Neurol; 2019 Jul; 266(7):1643-1648. PubMed ID: 30944980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic and prognostic value of cerebrospinal fluid SNAP-25 and neurogranin in Creutzfeldt-Jakob disease in a clinical setting cohort of rapidly progressive dementias.
    Bentivenga GM; Baiardi S; Mastrangelo A; Zenesini C; Mammana A; Polischi B; Capellari S; Parchi P
    Alzheimers Res Ther; 2023 Sep; 15(1):150. PubMed ID: 37684653
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of CSF and serum neurofilament light and heavy chain as differential diagnostic biomarkers for ALS.
    Halbgebauer S; Steinacker P; Verde F; Weishaupt J; Oeckl P; von Arnim C; Dorst J; Feneberg E; Mayer B; Rosenbohm A; Silani V; Ludolph AC; Otto M
    J Neurol Neurosurg Psychiatry; 2022 Jan; 93(1):68-74. PubMed ID: 34417339
    [TBL] [Abstract][Full Text] [Related]  

  • 45. TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.
    Hong S; Dobricic V; Ohlei O; Bos I; Vos SJB; Prokopenko D; Tijms BM; Andreasson U; Blennow K; Vandenberghe R; Gabel S; Scheltens P; Teunissen CE; Engelborghs S; Frisoni G; Blin O; Richardson JC; Bordet R; ; Lleó A; Alcolea D; Popp J; Clark C; Peyratout G; Martinez-Lage P; Tainta M; Dobson RJB; Legido-Quigley C; Sleegers K; Van Broeckhoven C; Tanzi RE; Ten Kate M; Wittig M; Franke A; Lill CM; Barkhof F; Lovestone S; Streffer J; Zetterberg H; Visser PJ; Bertram L
    Alzheimers Dement; 2021 Oct; 17(10):1628-1640. PubMed ID: 33991015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurofilament light chain in cerebrospinal fluid or blood as a biomarker for mild cognitive impairment: A systematic review and meta-analysis.
    Zhang J; Cheng H; Liu W; Li H; Song Y; Jia L
    Medicine (Baltimore); 2022 Mar; 101(9):e28932. PubMed ID: 35244049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias.
    Antonell A; Tort-Merino A; Ríos J; Balasa M; Borrego-Écija S; Auge JM; Muñoz-García C; Bosch B; Falgàs N; Rami L; Ramos-Campoy O; Blennow K; Zetterberg H; Molinuevo JL; Lladó A; Sánchez-Valle R
    Alzheimers Dement; 2020 Feb; 16(2):262-272. PubMed ID: 31668967
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus.
    Tyrberg T; Nilsson S; Blennow K; Zetterberg H; Grahn A
    J Neurovirol; 2020 Oct; 26(5):719-726. PubMed ID: 32816287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Non-APOE Polygenic Risk Score for Alzheimer's Disease Is Associated With Cerebrospinal Fluid Neurofilament Light in a Representative Sample of Cognitively Unimpaired 70-Year Olds.
    Skoog I; Kern S; Najar J; Guerreiro R; Bras J; Waern M; Zetterberg H; Blennow K; Zettergren A
    J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):983-990. PubMed ID: 33512503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neurofilament light chain is a promising serum biomarker in spinocerebellar ataxia type 3.
    Li QF; Dong Y; Yang L; Xie JJ; Ma Y; Du YC; Cheng HL; Ni W; Wu ZY
    Mol Neurodegener; 2019 Nov; 14(1):39. PubMed ID: 31684998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study.
    Gisslén M; Price RW; Andreasson U; Norgren N; Nilsson S; Hagberg L; Fuchs D; Spudich S; Blennow K; Zetterberg H
    EBioMedicine; 2016 Jan; 3():135-140. PubMed ID: 26870824
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrospinal fluid neurofilament light chain is a marker of aging and white matter damage.
    Meeker KL; Butt OH; Gordon BA; Fagan AM; Schindler SE; Morris JC; Benzinger TLS; Ances BM
    Neurobiol Dis; 2022 May; 166():105662. PubMed ID: 35167933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Serum and cerebrospinal fluid neurofilament light chain and glial fibrillary acid protein levels in early and advanced stages of cerebral amyloid Angiopathy.
    Rasing I; Voigt S; Koemans EA; de Kort AM; van Harten TW; van Etten ES; van Zwet EW; Stoops E; Francois C; Kuiperij HB; Klijn CJM; Schreuder FHBM; van der Weerd L; van Osch MJP; van Walderveen MAA; Verbeek MM; Terwindt GM; Wermer MJH
    Alzheimers Res Ther; 2024 Apr; 16(1):86. PubMed ID: 38654326
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.
    Gaetani L; Höglund K; Parnetti L; Pujol-Calderon F; Becker B; Eusebi P; Sarchielli P; Calabresi P; Di Filippo M; Zetterberg H; Blennow K
    Alzheimers Res Ther; 2018 Jan; 10(1):8. PubMed ID: 29370869
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases.
    Bacioglu M; Maia LF; Preische O; Schelle J; Apel A; Kaeser SA; Schweighauser M; Eninger T; Lambert M; Pilotto A; Shimshek DR; Neumann U; Kahle PJ; Staufenbiel M; Neumann M; Maetzler W; Kuhle J; Jucker M
    Neuron; 2016 Jul; 91(1):56-66. PubMed ID: 27292537
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Sleep disturbance in clinical and preclinical scrapie-infected sheep measured by polysomnography.
    Sola Fraca D; Sánchez Garrigós E; de Francisco Moure J; Marín Gonzalez B; Badiola Díez JJ; Acín Tresaco C
    Vet Q; 2024 Dec; 44(1):1-9. PubMed ID: 38698657
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
    Constantinescu R; Krýsl D; Bergquist F; Andrén K; Malmeström C; Asztély F; Axelsson M; Menachem EB; Blennow K; Rosengren L; Zetterberg H
    Eur J Neurol; 2016 Apr; 23(4):796-806. PubMed ID: 26822123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebrospinal fluid levels of neurofilament light chain in multiple system atrophy relative to Parkinson's disease: a meta-analysis.
    Hu X; Yang Y; Gong D
    Neurol Sci; 2017 Mar; 38(3):407-414. PubMed ID: 27896490
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 5-Methylcytosine and 5-Hydroxymethylcytosine in Scrapie-Infected Sheep and Mouse Brain Tissues.
    Hernaiz A; Sentre S; Betancor M; López-Pérez Ó; Salinas-Pena M; Zaragoza P; Badiola JJ; Toivonen JM; Bolea R; Martín-Burriel I
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675131
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cerebrospinal Fluid and Plasma Small Extracellular Vesicles and miRNAs as Biomarkers for Prion Diseases.
    López-Pérez Ó; Sanz-Rubio D; Hernaiz A; Betancor M; Otero A; Castilla J; Andréoletti O; Badiola JJ; Zaragoza P; Bolea R; Toivonen JM; Martín-Burriel I
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.